Emerging drugs on methicillin-resistantStaphylococcus aureus

Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors

(2016) Heather J. Adam et al.   Canadian Journal of Emergency Medicine

Comparative Analysis of the Antibacterial Activity of a Novel Peptide Deformylase Inhibitor, GSK1322322

(2013) Karen O'Dwyer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemics of Community-Associated Methicillin-Resistant Staphylococcus aureus in the United States: A Meta-Analysis

(2013) Vanja M. Dukic et al.   PLoS One

In VitroActivity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections

(2012) Philippe Prokocimer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States

(2012) Rodrigo E. Mendes et al.   CLINICAL INFECTIOUS DISEASES

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

(2012) R. G. Wunderink et al.   CLINICAL INFECTIOUS DISEASES

Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials

(2012) P. Prasad et al.   CLINICAL INFECTIOUS DISEASES

Bacterial Cell Wall Compounds as Promising Targets of Antimicrobial Agents II. Immunological and Clinical Aspects

(2012) Tobias Schuerholz et al.   CURRENT DRUG TARGETS

New therapy options for MRSA with respiratory infection/pneumonia

(2012) Paula Ramirez et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Tedizolid (TR-701): a new oxazolidinone with enhanced potency

(2012) Zeina A. Kanafani et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The oxazolidinones: past, present, and future

(2011) Karen Joy Shaw et al.   Annals of the New York Academy of Sciences

Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization

(2011) Elisabet I. Nielsen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

(2011) Nagendra N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial

(2011) Lala M. Dunbar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs*

(2011) Pilar Martinez-Olondris et al.   CRITICAL CARE MEDICINE

Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors

(2011) J. B. Parsons et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates

(2010) T.-L. Lauderdale et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020

(2010)   CLINICAL INFECTIOUS DISEASES

Not Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA)! A Clinician's Guide to Community MRSA - Its Evolving Antimicrobial Resistance and Implications for Therapy

(2010) K. Chua et al.   CLINICAL INFECTIOUS DISEASES

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia

(2010) Antonio T. Freire et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

New Lipoglycopeptides

(2010) George G. Zhanel et al.   DRUGS

Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options

(2010) Tobias Welte et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit

(2010) Miguel Sánchez García   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes

(2010) Pierre Baudoux et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Essentiality of FASII pathway for Staphylococcus aureus

(2010) Wendy Balemans et al.   NATURE

Current and novel antibiotics against resistant Gram-positive bacteria

(2010) Federico Perez   Infection and Drug Resistance

Iclaprim, a Novel Diaminopyrimidine for the Treatment of Resistant Gram-Positive Infections

(2009) Carrie A Sincak et al.   ANNALS OF PHARMACOTHERAPY

Multicenter, Randomized Study of the Efficacy and Safety of Intravenous Iclaprim in Complicated Skin and Skin Structure Infections

(2009) D. Krievins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates

(2009) H. S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

(2009) C. M. Rubino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA

(2009) K. C. Horne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications*

(2009) Andrew F. Shorr et al.   CRITICAL CARE MEDICINE

Productive steps toward an antimicrobial targeting virulence

(2009) Amy K Barczak et al.   CURRENT OPINION IN MICROBIOLOGY

What is MRSA?

(2009) A. Pantosti et al.   EUROPEAN RESPIRATORY JOURNAL

The role of telavancin in the treatment of MRSA infections in hospital

(2009) Matteo Bassetti et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Lack of community-associated MRSA in Rome

(2009) G.B. Orsi et al.   JOURNAL OF HOSPITAL INFECTION

Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens

(2009) Sophie Brinster et al.   NATURE

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

(2008) M. Rybak et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

(2008) Y. Ge et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus

(2008) H. S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic

(2008) L. D. Saravolatz et al.   CLINICAL INFECTIOUS DISEASES

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

Complicated Skin and Skin‐Structure Infections and Catheter‐Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study

(2008) Mark H. Wilcox et al.   CLINICAL INFECTIOUS DISEASES

Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.

(2008) S. Roveta et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pleiotropic Roles of Polyglycerolphosphate Synthase of Lipoteichoic Acid in Growth of Staphylococcus aureus Cells

(2008) Y. Oku et al.   JOURNAL OF BACTERIOLOGY